Esperion Therapeutics | Des Atouts

Prix De L'Action
3.37
Variation Quotidienne
0.05 1.51%
Mensuellement
-5.07%
Annuel
88.27%
Q1 Prévisions
2.70




Des Atouts Changement Date
AbbVie USD 133.9B 3.28B 2025-09
Alnylam Pharmaceuticals USD 4.85B 285.64M 2025-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amarin USD 659.81M 10.31M 2025-09
Amgen USD 90.59B 445M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Cipla INR 401.64B 27.77B 2025-09
CSL USD 39.4B 957M 2025-06
Cytokinetics USD 1.44B 210.92M 2025-09
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 114.94B 14.01B 2025-09
Esperion Therapeutics USD 364.02M 16.93M 2025-09
Geron USD 567.38M 12.18M 2025-09
Grifols EUR 23.29B 3.35M 2025-09
Halozyme Therapeutics USD 2.22B 167.33M 2025-09
Heron Therapeutics USD 248.95M 16.86M 2025-09
Ionis Pharmaceuticals USD 3.03B 47.96M 2025-09
Merck USD 129.55B 12.02B 2025-09
Minerva Neurosciences USD 28.09M 2.33M 2025-09
Moderna USD 12.14B 125M 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
PTC Therapeutics USD 2.64B 9.54M 2025-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
United Therapeutics USD 7.35B 556.9M 2025-09
Vanda Pharmaceuticals USD 601.14M 23.61M 2025-09


Esperion Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.